FDA product code GXE: Leukotome

GXE is the FDA product code for leukotome. It is a Class I device, regulated under 21 CFR 882.4600 and reviewed by the Neurology panel. FDA has cleared 1 510(k) submission under GXE. The average 510(k) review took 354 days (median 354). FDA has posted 1 recall for GXE devices.

Classification

FieldValue
Device nameLeukotome
Device classClass I
Regulation21 CFR 882.4600
Review panelNE — Neurology
Medical specialtyNeurology
Premarket route510(k) exempt

Compare with all 510(k) review times · Search every GXE clearance

Top GXE applicants

ApplicantClearancesLatest
Dantec Medical, Inc.11992-12-08

Most recent GXE clearances

510(k)ApplicantDeviceDecision dateReview days
K915741Dantec Medical, Inc.DISPOSABLE MONOPLAR MEDDLE ELECTRODES1992-12-08354

Recalls for GXE devices

1 product recalls in 1 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2006-01-17.

Frequently asked questions

What is FDA product code GXE?

GXE is the FDA product code for leukotome. It is a Class I device, regulated under 21 CFR 882.4600 and reviewed by the Neurology panel.

What device class is GXE?

Class I, regulation 21 CFR 882.4600. Typical premarket route: 510(k) exempt.

How long does a 510(k) take for product code GXE?

Across 1 cleared submissions the average was 354 days from receipt to decision (median 354).

Which companies have the most GXE clearances?

Dantec Medical, Inc. (1).

Have GXE devices been recalled?

Yes: 1 product recalls across 1 recall events; the most recent began 2006-01-17.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Neurology product codes · FDA product code lookup · 510(k) database search · 510(k) review times